Medical Isotopes / Commercial Production Of Lutetium-177 Begins At Bruce Nuclear Plant

Radioisotope important for precision oncology treatments
Commercial Production Of Lutetium-177 Begins At Bruce Nuclear Plant
Bruce-7 will be the world's first commercial reactor unit to be used in Lutetium-177 production. Image courtesy Bruce Power.
Commercial production of lutetium-177 (Lu-177) has started at Unit 7 of the Bruce nuclear power station in Ontario, owner and operator Bruce Power of Canada said.

The development marks the world’s first commercial production of the radioisotope at a commercial nuclear reactor unit.

Want to keep reading?

Register free and get full access to NucNet for 14 days. No card required.

Republish or license this article

MORE THAN 30 YEARS OF NUCLEAR INDUSTRY REPORTING.

Subscribe for full access to every article, the archive and the SMR and AMR database.

Join NucNet